Updated recommendations for the diagnosis, treatment, prevention, and outbreak management of seasonal influenza.
Just in time for this flu season, the Infectious Diseases Society of America (IDSA) has issued updated recommendations for healthcare professionals for the diagnosis, treatment, prevention, and outbreak management of seasonal influenza.
The new guidelines–the first update in 10 years–focus on three areas: adding groups to those at high risk for flu complications, recommending use of newer fast and accurate molecular tests to diagnose influenza, and prescribing antiviral medications for those at high risk even if they have been sick for more than two days.
Trending: Tax Cuts and Jobs Act of 2017 Affecting Pharmacy Accounting
Andrew Pavia, MD, professor and chief of infectious diseases at the University of Utah in Salt Lake City and part of the IDSA committee updating the guidelines, notes the last recommendations were released before the 2009 H1N1 epidemic.
“Since 2008, we have really developed a lot of new evidence about when and where antivirals work,” Pavia tells Drug Topics. “It’s important to get the message out. They can be life-saving to those with high risk of complications. They are important to people with high risk whether they are hospitalized or not.”
The new guidelines include:
HHS Awards Moderna $176 Million to Develop Pandemic-Ready Influenza Vaccine
July 4th 2024“Adding this technology to our pandemic flu toolkit enhances our ability to be nimble and quick against the circulating strains and their potential variants,” said Dawn O’Connell, assistant secretary for preparedness and response at the HSS.
HHS Awards Moderna $176 Million to Develop Pandemic-Ready Influenza Vaccine
July 4th 2024“Adding this technology to our pandemic flu toolkit enhances our ability to be nimble and quick against the circulating strains and their potential variants,” said Dawn O’Connell, assistant secretary for preparedness and response at the HSS.
2 Commerce Drive
Cranbury, NJ 08512